POPULAR SECTIONS

TREATMENT REGIMENS DRUG INFO MEDICAL CALCULATORS PUBLISHERS ALLIANCE VIDEOS CME

Genitourinary Cancers Symposium 2013


Expert-Recommended Abstracts

ChemotherapyAdvisor.com Editorial Board Recommends High-Impact Abstracts from the 2013 Genitourinary Cancers Symposium

ChemotherapyAdvisor.com Editorial Board Recommends High-Impact Abstracts from the 2013 Genitourinary Cancers Symposium

Dr. Neal Shore, MD, FACS, of Atlantic Urology Clinics shares his list of recommended abstracts that will be presented at the 2013 Genitourinary Cancers Symposium.

Latest News

GU Symposium Report: New Drug Combinations Improve Prostate Cancer Outcomes

GU Symposium Report: New Drug Combinations Improve Prostate Cancer Outcomes

Survival rates rise as newer agents are used in combination therapies for patients with advanced prostate cancer.

ASCO GU: Finasteride Reduces Risk of Prostate Cancer Diagnosis

ASCO GU: Finasteride Reduces Risk of Prostate Cancer Diagnosis

Use of finasteride reduces the risk of a prostate cancer diagnosis, but does not significantly affect mortality rates after following men for 18 years, according to a study presented at the 2013 Genitourinary Cancers Symposium.

ASCO GU: Anticoagulant Use Predicts Metastatic Prostate CA Survival

ASCO GU: Anticoagulant Use Predicts Metastatic Prostate CA Survival

Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of mCRPC, according to research presented at the 2013 Genitourinary Cancers Symposium.

Urine-Based Biomarker Assay Can Detect Bladder Cancer Noninvasively

A urine-based assay "can markedly improve the accuracy" of detecting bladder cancer noninvasively, according to a case-controlled validation study reported during the 2013 Genitourinary Cancers Symposium.

No OS Difference Between Tivozanib and Sorafenib for Advanced Renal Cell Carcinoma

No significant difference in overall survival was found between tivozanib and sorafenib in patients with advanced renal cell carcinoma, according to research presented at the 2013 Genitourinary Cancers Symposium.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs